Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-014414-98Phase 2Completed
Phase 2 trial of ibandronic acid in hip osteoarthritis, sponsored by Department of Orthopaedic Surgery, University Hospital Linköping. Primary endpoint: Periprosthetic bone resorption and fixation stability. Started Sep 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-014414-98.